NIH-funded research R01 grant

Understanding cerebrospinal fluid flow in Huntington's disease

Official title: Cerebrospinal fluid dynamics in Huntington's disease

Funded at Vanderbilt University Medical Center · NIH-11062117 · Data updated 2026-11-12

This study is looking at how the fluid around your brain and spine works in people with Huntington's disease, and it hopes to find out if new treatments can help improve this fluid flow and overall health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$621,073
NIH project number1R01NS141191-01
Project IDNIH-11062117 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with Huntington's disease who are 21 years or older.

Less likely to help

Patients with other neurological conditions unrelated to Huntington's disease may not benefit from this research.

What this research studies

This research investigates how cerebrospinal fluid (CSF) is produced, transported, and absorbed in patients with Huntington's disease. By using advanced neuroimaging techniques, the study aims to understand the effects of abnormal CSF circulation on the progression of the disease. The research also explores the potential impact of new treatments, specifically antisense oligonucleotides, on CSF dynamics and patient outcomes. Collaborations among neurologists and imaging experts enhance the study's approach to understanding neurodegeneration.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for patients with Huntington's disease by optimizing CSF flow and enhancing the effectiveness of new therapies.

How similar studies have gone: Previous research has shown promising results in understanding neurofluid dynamics in other neurodegenerative diseases, suggesting potential for success in this novel approach.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Claassen, Daniel Oliver — Vanderbilt University Medical Center
  • Study coordinator: Claassen, Daniel Oliver

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.